#Lightspeed

OpenAI Researcher Leaves to Build AI Drug Discovery Startup, Seeking $200M at $2B Valuation

Miles Wang, who studied how AI can speed up science, is reportedly heading out of OpenAI to start a company focused on finding new medicines faster.